Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chick welfare in a large, commercial chicken hatchery: A case study.

Open veterinary journal·2026
Same author

Comparative Analysis of Extraction Complications in Transvenous Versus Leadless Pacemakers.

Cureus·2026
Same author

General practitioners do not need to be certain; they need to be safe.

Australian journal of general practice·2026
Same author

The Digestibility of Vegan and Vegetarian Diets for Dogs and Cats.

Animals : an open access journal from MDPI·2026
Same author

Beyond empiric checkpoint escalation: Insights from KEYVIBE-010.

Med (New York, N.Y.)·2026
Same author

Effectiveness of Data-Driven Quality Improvement on Hospitalizations and Health Outcomes for People With Coronary Heart Disease in Primary Care (QUEL): A Cluster Randomized Controlled Trial With 24-Month Follow-Up.

Circulation. Population health and outcomes·2026

Related Experiment Video

Updated: Jun 29, 2026

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

Non-animal methodologies within biomedical research and toxicity testing.

Andrew Knight1

  • 1Animal Consultants International, London, UK.

ALTEX
|October 9, 2008
PubMed
Summary

Non-animal testing methods offer faster, more reliable results for human health and chemical safety. Advancing these alternative models is crucial for high-throughput screening and drug development.

Area of Science:

  • Biomedical Research
  • Toxicology
  • In Vitro and In Silico Methods

Background:

  • Laboratory animal models face limitations in human applicability and increasing regulatory scrutiny.
  • High-throughput chemical testing programs encounter significant logistical challenges with traditional animal models.
  • Societal concerns are driving restrictions on animal testing.

Purpose of the Study:

  • To explore and highlight the range of available non-animal methodologies in biomedical research and toxicity testing.
  • To emphasize the potential of alternative models for high-throughput chemical testing and drug development.
  • To advocate for increased development and implementation of non-animal testing strategies.

Main Methods:

  • Data sharing and assessment prior to new studies.

More Related Videos

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity
04:47

Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity

Published on: October 28, 2013

Related Experiment Videos

Last Updated: Jun 29, 2026

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity
04:47

Autonomously Bioluminescent Mammalian Cells for Continuous and Real-time Monitoring of Cytotoxicity

Published on: October 28, 2013

  • Physicochemical evaluation and computational modeling (e.g., structure-activity relationships, expert systems).
  • Use of microorganisms, higher plants, and minimally-sentient organisms.
  • In vitro assays utilizing various cell cultures (bacterial, yeast, protozoal, mammalian, human), including human hepatocyte cultures and metabolic activation systems.
  • Microarray technology for gene expression profiling.
  • Enhanced human clinical trials (micro-dosing, staggered dosing, representative populations), surrogate human tissues, advanced imaging, and epidemiological studies.

    • Main Results:

    • Non-animal models, particularly those using human tissues, can yield faster, cheaper, and more human-predictive results.
    • These methods provide deeper insights into human biochemical processes and disease mechanisms.
    • Alternative methods like in vitro assays and computational modeling are suitable for a wide range of toxicological endpoints.

    Conclusions:

    • Non-animal methodologies present a viable and often superior alternative to traditional animal testing.
    • Greater commitment to developing and implementing these methods is essential for meeting current and future testing needs.
    • Advancing non-animal models will accelerate chemical safety assessment and the development of effective human therapies.